HAIFA, Israel and MIAMI, Feb. 10, 2021 /PRNewswire/ — Insightec®, a global healthcare company focused on creating the next generation of patient care, announced it received market approval by The National Medical Products Administration (NMPA), the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administration, or CFDA).

Read more here.